Analisis Efektivitas Biaya Penggunaan Antihipertensi Kombinasi Dua Obat Pada Pasien Hipertensi Rawat Jalan Di Rumah Sakit Umum Daerah Dr. Moewardi Tahun 2012

Hypertension is one of the major factors of risk of death from cardiovascular disorders that result in 20-50% of all deaths. Health financing in Indonesia increase, the cost-effectiveness analysis is needed in order to assist in decision making these medicines are effective benefits and cost. This s...

Full description

Saved in:
Bibliographic Details
Main Authors: Ernawati, Yuli (Author), , Dr. dr. EM. Sutrisna, M.Kes (Author), , Tanti Azizah Sujono, M.Sc., Apt (Author)
Format: Book
Published: 2016.
Subjects:
Online Access:Connect to this object online
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hypertension is one of the major factors of risk of death from cardiovascular disorders that result in 20-50% of all deaths. Health financing in Indonesia increase, the cost-effectiveness analysis is needed in order to assist in decision making these medicines are effective benefits and cost. This study aims to determine the antihypertensive combination of the most cost-effective in the Hospital Dr. Moewardi in 2012. This study is a non-experimental descriptive. The data collection was done retrospectively based on medical records, laboratory and administrative price ceilings on drugs. Cost-effectiveness analysis was done by comparing large direct medical costs on average per month against the percentage of patients reaching blood pressure targets based on parameter ACER. The results showed 8 pattern combinations used patient is beta blockers with ACE-inhibitor, ARBs with hidrochlorothiazid, ARB with CCB, ARB with beta blockers, ACE-inhibitor with diuretics hidrochlorothiazid, ACE-inhibitors with furosemide, ACE-inhibitorwith ARBs, ACE -Inhibitor with CCB. The pattern of treatment which is the most cost-effective for patients with hypertension based on effectiveness of decreasing blood pressure to reach the target was with ACE-inhibitors with hidrochlorothiazid with amounted490,69 ACER and ICER -13.663,68.
Item Description:https://eprints.ums.ac.id/46790/15/NASKAH%20PUBLIKASI.pdf
https://eprints.ums.ac.id/46790/2/HALAMAN%20DEPAN.pdf
https://eprints.ums.ac.id/46790/3/BAB%201.pdf
https://eprints.ums.ac.id/46790/4/BAB%202.pdf
https://eprints.ums.ac.id/46790/10/BAB%203.pdf
https://eprints.ums.ac.id/46790/11/BAB%204.pdf
https://eprints.ums.ac.id/46790/12/DAFTAR%20PUSTAKA.pdf
https://eprints.ums.ac.id/46790/13/LAMPIRAN.pdf
https://eprints.ums.ac.id/46790/14/SURAT%20PERNYATAAN%20PUBLIKASI.pdf